Viewing StudyNCT00217295



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217295
Status: UNKNOWN
Last Update Posted: 2005-09-22
First Post: 2005-09-14

Brief Title: A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Sponsor: Multiple Sclerosis Institute
Organization: Multiple Sclerosis Institute

Organization Data

Organization: Multiple Sclerosis Institute
Class: OTHER
Study ID: MSI-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Multiple Sclerosis Institute
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators